Interstitial pneumonia with autoimmune features (IPAF) is a subcategory of idiopathic interstitial pneumonia (IIP) that has clinical, serologic, and/or imaging features consistent with an autoimmune disease but does not meet criteria for a more well-defined connective tissue disease-associated interstitial lung disease (CTD-ILD). Since the recent creation of diagnostic criteria in 2015, there has been more research examining the population characteristics, pathophysiologic processes, prognostic factors, and treatment options for patients with this disease entity. Despite the increasing and evolving data, there are currently no established treatment regimens, and controversies regarding the diagnostic criteria remain. In light of this, it is extraordinarily important to promote rheumatology and pulmonology collaboration in the holistic care of patients with IPAF. <!----> <!----> <!----> <!---->